Table 2.
Outcomes and bias of trials with a focus on gestational weight gain, obesity, and physical activity.
Reference | Participant age (years), mean (SD) | Attrition rate | Main outcomes | Bias tool | Bias rating | Bias reasoning |
Soltani et al (2015) [28] | 29.1 (5.4) for IGa vs 31.7 (5.8) for CGb | 13% (2/16) |
|
NIH QATe | Fair risk | Small sample size |
Choi et al (2016) [30] | 32.9 (2.5) for IG vs 34.5 (2.5) in CG | 40% to daily messages, 33% to activity diary |
|
Cochrane ROBTg | Low risk | N/Ah |
Herring et al (2016) [31] | 25.9 (4.9) for IG vs 25.0 (5.7) for CG | Unclear |
|
Cochrane ROBT | Low risk | N/A |
Dodd (2017) [32] | 30.87 (5.07) for IG vs 31.01 (6.16) for CG | 38.2% (62/162) |
|
Cochrane ROBT | High risk | High attrition, self-report, and women knew allocations |
Willcox (2017) [33] | 33.0 (3.4) for IG vs 32.0 (5.1) for CG | 9.0% (9/100) |
|
Cochrane ROBT | High risk | Women not blinded, self-reported exercise |
Pollak (2014) [34] | 29 (5) for IG vs 32 (2) in CG | 30% (10/33) |
|
Cochrane ROBT | High risk | High proportional attrition, low sample size. Possibly randomized by study staff |
Huberty (2017) [35] | 31.05 (5.52) for Plus One vs 31.48 (5.44) for Plus Six vs 31.44 (4.16) for Plus Six Choice vs 30.83 (5.22) for standard | 14% (13/93) |
|
Cochrane ROBT | Fair risk | Not blinded |
Redman (2017) [36] | 29.0 (4.2) for remote vs 29.2 (4.8) for in person vs 29.5 (5.1) for CG | Unclear |
|
Cochrane ROBT | High risk | Randomized by unblinded intervention staff |
Kennelly (2018) [37] | 32.8 (4.6) for IG vs 32.1 (4.2) for CG | 11.9% (67/565) |
|
Cochrane ROBT | Fair risk | Self-reported exercise and food outcomes; neither participants nor researchers blinded |
aIG: intervention group.
bCG: control group.
cGWG: gestational weight gain.
dIOM: Institute of Medicine.
eNIH QAT: National Institutes of Health Quality Assessment Tool.
fCES-D: Center for Epidemiologic Studies Depression Scale.
gN/A: not applicable.
hROBT: risk of bias tool.
iGDM: gestational diabetes mellitus.